3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
12
Multiple Myeloma
11
Lymphoma
10
Neoplasm Metastasis
9
Melanoma
7
Leukemia, Myeloid, Acute
7
Prostatic Neoplasms
6
Neuroblastoma
6
Carcinoma, Non-Small-Cell Lung
6
Wilms Tumor
5
Medulloblastoma
5
Lymphoma, Non-Hodgkin
5
Fallopian Tube Neoplasms
5
Burkitt Lymphoma
5
Breast Neoplasms
5
Triple Negative Breast Neoplasms
4
Small Cell Lung Carcinoma
4
Rhabdoid Tumor
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Osteosarcoma
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Histiocytosis, Langerhans-Cell
4
Hepatoblastoma
4
Glioma
4
Ependymoma
4
Central Nervous System Neoplasms
4
Sarcoma, Kaposi
3
Sarcoma
3
Interventions
Melphalan
5
fludarabine phosphate
3
fludarabine
3
Whole-Body Irradiation
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Cyclophosphamide
3
Tacrolimus
2
pomalidomide
1
ixazomib
1
elotuzumab
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
carmustine, poliferprosan 20 drug combination
1
carfilzomib
1
auricularum
1
Stem Cell Transplantation
1
Sirolimus
1
Panobinostat
1
Lenalidomide
1
High-Throughput Screening Assays
1
Gemcitabine
1
Filgrastim
1
Etoposide
1
Dexamethasone
1
Cytarabine
1
Carmustine
1
Calcium Dobesilate
1
Busulfan
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Plasma Cell
×
Specimen Handling
×
Clear all
No trials found.